CLOV vs PHAT
Clover Health Investments Corp (CLOV) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
CLOV currently screens at market cap $1.55B. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the CLOV and PHAT stock pages for the full models.
Not investment advice.